A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

Article was originally published https://www.wired.com/story/a-cutting-edge-cancer-treatment-is-under-fda-investigation-for-cancer-risk/

Related posts